Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.28
+0.11 (2.13%)
Nov 20, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
$47,268
Profits / Employee
-$1,030,125
Market Cap
200.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 516 |
| ADC Therapeutics | 274 |
| Sight Sciences | 214 |
| Enanta Pharmaceuticals | 145 |
| Nektar Therapeutics | 137 |
| Profound Medical | 131 |
| Acrivon Therapeutics | 61 |
| Lexeo Therapeutics | 58 |
OBIO News
- 8 days ago - Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 6 months ago - Orchestra BioMed to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 7 months ago - Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents - GlobeNewsWire
- 8 months ago - Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 8 months ago - Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors - GlobeNewsWire
- 9 months ago - Orchestra BioMed to Participate in Upcoming Investor Conferences - GlobeNewsWire